mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.2 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.2 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.2 |
mRNA |
NSC 74859 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.2 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.2 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.2 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.2 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.2 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.2 |